Latest Growth Opportunities News

Mamba Exploration Limited has exited its earn-in agreement on the Canary Uranium Project, redirecting focus to other assets, while successfully raising $850,000 through a two-tranche placement to bolster its cash position.

Leo Lithium Limited reports a robust cash position of $269.3 million following the sale of a 40% stake in MLBV, underpinning its financial strength amid ongoing operational expenditures.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

Prominence Energy reports steady progress in its uranium and gas exploration projects while pursuing new growth opportunities focused on capital efficiency and operational flexibility.

Aumake Limited reported a remarkable 239% increase in quarterly cash receipts, driven by a $16 million purchase order from Yangtze River and a strategic capital raise, positioning the company for robust growth in 2025.

Karoon Energy plans to expand its on-market share buyback program by an additional US$75 million, aiming to invest a total of US$125 million in shares by the end of 2025 amid a belief that its stock is undervalued.

Nanoveu Limited has appointed industry veteran Mark Goranson as CEO of its Semiconductor Technologies division, positioning the company to accelerate growth in ultra-low-power AI-driven chips following its EMASS acquisition.

Mach7 Technologies has initiated a A$5 million on-market share buy-back program, reflecting confidence in its robust financial health and growth outlook. The move underscores the company’s commitment to capital management amid reaffirmed FY25 revenue growth guidance.

Locality Planning Energy Holdings (LPE) reports a cashflow positive half-year and reduces debt, while securing a landmark energy management contract for Queensland's largest social housing project.

SciDev Ltd reports a seasonal revenue dip in Q2 FY25 due to US Oil & Gas sector uncertainty but marks a strategic milestone by securing its first PFAS treatment contracts in Europe.

Zip Co Limited has posted record-breaking second quarter results for FY25, driven by exceptional holiday trading and robust growth in the US and ANZ markets. The company reported a 24.8% increase in Total Transaction Volume and a 50.2% rise in cash EBTDA.

Doctor Care Anywhere delivered positive cash flow and revenue growth at the top of guidance in Q4 2024, while navigating a strategic shift with new leadership appointments and the closure of secondary care pathways.